Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

1,900

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

October 1, 2027

Conditions
Human Papillomavirus-Related Carcinoma
Interventions
OTHER

Best Practice

Provide vaccinations per usual care

OTHER

Educational Intervention

Review messages on safety and side effects

OTHER

Educational Intervention

Review messages on vaccine effectiveness

OTHER

Educational Intervention

Review messages on sexual activity

OTHER

Educational Intervention

Review messages on HPV vaccine for boys

OTHER

Educational Intervention

Review message on age to start vaccine

OTHER

Educational Intervention

Review messages on school entry requirements

OTHER

Interview

Ancillary studies

OTHER

Questionnaire Administration

Complete a survey

OTHER

Questionnaire Administration

Ancillary studies

BEHAVIORAL

Training and Education

Receive interpersonal communication training

BEHAVIORAL

Training and Education

Receive the vaccination workflow training

PROCEDURE

Vaccination

Provide vaccinations using the interpersonal communication strategy

PROCEDURE

Vaccination

Provide vaccinations using the vaccination workflow training strategy

PROCEDURE

Vaccination

Provide vaccinations using both the interpersonal communication strategy and the vaccination workflow training strategy

Trial Locations (2)

16802

Penn State University, University Park

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Fred Hutchinson Cancer Center

OTHER

NCT06926062 - Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial | Biotech Hunter | Biotech Hunter